Currently out of the existing stock ratings of Wangzhi Li, 25 are a BUY (92.59%), 2 are a HOLD (7.41%).

Wangzhi Li

Work Performance Price Targets & Ratings Chart

Analyst Wangzhi Li, carries an average stock price target met ratio of 47.22% that have a potential upside of 59% achieved within 346 days. Previously, Wangzhi Li worked at LADENBURG.

Wangzhi Li’s has documented 49 price targets and ratings displayed on 9 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on BGNE, BeiGene Ltd at 08-Dec-2020.

Wall Street Analyst Wangzhi Li

Analyst best performing recommendations are on ARCT (ARCTURUS THERAPEUTICS HOLDINGS).
The best stock recommendation documented was for ARCT (ARCTURUS THERAPEUTICS HOLDINGS) at 3/4/2020. The price target of $28 was fulfilled within 54 days with a profit of $11.22 (66.87%) receiving and performance score of 12.38.

Average potential price target upside

of $38.98 (21.44%) on BGNE (BEIGENE LTD).
of $24.98 (140.77%) on KRYS (KRYSTAL BIOTECH).
of $13.65 (169.25%) on ARCT (ARCTURUS THERAPEUTICS HOLDINGS).

BGNE BeiGene Ltd ARCT Arcturus Therapeutics Holdings BLCM Bellicum Pharmaceuticals CLLS Cellectis SA KRYS Krystal Biotech ALPN Alpine Immune Sciences APVO Aptevo Therapeutics FBRX Forte Biosciences LPTX Leap Therapeutics

Show more stocks

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score